Cartesian Therapeutics, Inc.
Descartes-08
juvenile dermatomyositis
Countdown
358days
Catalyst readout · ~ Jun 30, 2027 estimated
What's at stake
A key catalyst for Descartes-08 (juvenile dermatomyositis) is expected ~ Jun 30, 2027.
Primary source
· SEC 8-K
verified 13h ago
“clinical data from the Phase 1/2 HELIOS pediatric trial is expected in the first half of 2027”